查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701316

磺達肝癸鈉市場規模、佔有率、趨勢分析報告：按類型、產品、分銷管道、地區和細分市場預測，2025 年至 2030 年

Fondaparinux Market Size, Share & Trends Analysis Report By Type (Deep Vein Thrombosis), By Product (Branded, Generic), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

磺達肝癸鈉市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，到2030年全球磺達肝癸鈉市場規模預計將達到9.909億美元，預計2025年至2030年期間的複合年成長率為6.3%。

磺達肝癸鈉主要用於膝關節和髖關節關節重建置換術。 Arixtra 由葛蘭素史克集團生產，是磺達肝癸鈉的品牌藥。該藥物的專利於 2002 年到期。這種活性分子的製造非常複雜，因此直到 2011 年才出現學名藥的競爭。 Alchemia 和 Apotex 等非專利製造商於 2011 年獲得了簡化新藥認證，並立即開始生產學名藥。

磺達肝癸鈉是一種抗凝血劑，與低分子量肝素相比，存活率較高。它用於預防深層靜脈栓塞症(DVT) 和肺動脈栓塞(PE)，並透過皮下給藥。此外，磺達肝癸鈉還可降低缺血事件的風險。

預計主要參與企業之間加強合作，透過專利技術獲得製造分子的智慧財產權（IPR）將推動成長。例如，2016年7月，雷迪博士實驗室有限公司與Alchemia有限公司達成協議，以1,750萬美元購買磺達肝癸鈉的智慧財產權。 2014 年 9 月，Mylan NV 以 2.25 億美元的價格從 Aspen Worldwide, Inc. 收購了磺達肝癸鈉的品牌藥和學名藥。該交易使邁蘭公司能夠獲得兩種用於治療 PE 的學名藥之一。

磺達肝癸鈉市場報告重點

  • 預計學名藥將在 2024 年佔據最大的銷售佔有率，達到 52.1%，並在預測期內保持主導地位。
  • 2024 年，深層靜脈栓塞症(DVT) 部分將佔據市場的大部分佔有率。
  • 2024年，醫院藥局將成為磺達肝癸鈉的主要通路
  • 北美磺達肝癸鈉市場在全球市場中佔據主導地位，2024年佔最大銷售佔有率，為37.6%。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 磺達肝癸鈉市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析

第4章 磺達肝癸鈉市場：類型業務分析

  • 2024年和2030年的類型市場佔有率
  • 類型細分儀表板
  • 按類型分類的市場規模、預測和趨勢分析（2018-2030 年）
  • 深層靜脈栓塞症
  • 肺動脈栓塞

第5章 磺達肝癸鈉市場：產品業務分析

  • 2024年及2030年的產品市場佔有率
  • 產品細分儀表板
  • 市場規模、預測與趨勢分析（按產品，2018-2030 年）
  • 品牌
  • 非專利的

6. 磺達肝癸鈉市場：通路業務分析

  • 2024年及2030年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 按分銷管道分類的市場規模、預測和趨勢分析（2018-2030 年）
  • 醫院藥房
  • 零售藥局
  • 網路藥局

7. 磺達肝癸鈉市場：區域、估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年各國情況
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年各國情況
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030年各國情況
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年各國情況
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Abbott Laboratories Inc.
    • Alchemia Limited
    • Apotex Inc.
    • GSK plc
    • Lupin Pharmaceuticals, Inc
    • ScinoPharm Taiwan Ltd
    • Dr. Reddy's Laboratories Ltd.
    • Bayer Healthcare AG
    • GlaxoSmithKline
    • Boehringer Ingelheim
    • Sanofi
    • WisMed
    • Kaifeng
    • Mylan
Product Code: 978-1-68038-960-9

Fondaparinux Market Growth & Trends:

The global fondaparinux market size is estimated to reach USD 990.9 million by 2030, registering to grow at a CAGR of 6.3% from 2025 to 2030 according to a new report by Grand View Research, Inc. Fondaparinux is majorly used during knee and hip replacement surgeries. Arixtra, manufactured by GSK group of companies is the branded drug of Fondaparinux. The drug witnessed patent expiry in 2002. As the active molecule is highly complex to manufacture, it faced low generic competition until 2011. Generic manufacturer companies, such as Alchemia Ltd. and Apotex, Inc., received the Abbreviated New Drug Application approval in 2011 and instantly started the production of generic drugs.

Fondaparinux is used as an anticoagulant and shows improved survival compared with low-molecular-weight heparin. It is used for the prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and is administered subcutaneously. Moreover, Fondaparinux lowers the risk of ischemic events

The increasing collaboration between the key players for acquiring the Intellectual Property Rights (IPRs) in order to manufacture the molecule through patented technology is expected to drive growth. For instance, in July 2016 Dr. Reddy's Laboratories Ltd. entered into an agreement with Alchemia Ltd. to purchase the IPRs of fondaparinux sodium for USD 17.5 million. In September 2014, Mylan N.V. purchased branded and generic versions of fondaparinux sodium from Aspen Global, Inc. for USD 225 million. The deal gave Mylan N.V. access to one of the two generics indicated for the treatment of PE.

Fondaparinux Market Report Highlights:

  • The generic segment accounted for the largest revenue share of 52.1% in 2024 and is expected to maintain its dominance during the forecast period.
  • The Deep Vein Thrombosis (DVT) segment accounted for a leading share of the market in 2024.
  • Hospital pharmacies emerged as the leading distribution channel for fondaparinux in 2024
  • North America fondaparinux market dominated the global market and accounted for the largest revenue share of 37.6% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Fondaparinux Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Fondaparinux Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Deep Vein Thrombosis
    • 4.4.1. Deep Vein Thrombosis Market, 2018 - 2030 (USD Million)
  • 4.5. Pulmonary Embolism
    • 4.5.1. Pulmonary Embolism Market, 2018 - 2030 (USD Million)

Chapter 5. Fondaparinux Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Branded
    • 5.4.1. Branded Market, 2018 - 2030 (USD Million)
  • 5.5. Generic
    • 5.5.1. Generic Market, 2018 - 2030 (USD Million)

Chapter 6. Fondaparinux Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 7. Fondaparinux Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. South Korea Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Abbott Laboratories Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Alchemia Limited
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Apotex Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. GSK plc
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Lupin Pharmaceuticals, Inc
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. ScinoPharm Taiwan Ltd
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Dr. Reddy's Laboratories Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives.
    • 8.5.8. Bayer Healthcare AG
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. GlaxoSmithKline
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Boehringer Ingelheim
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Sanofi
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. WisMed
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Kaifeng
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Mylan
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Fondaparinux Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Global Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 North America Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Mexico Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Mexico Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 UK Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 25 UK Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 UK Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 Germany Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 France Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 France Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 France Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Italy Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 Italy Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Spain Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Spain Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Denmark Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 Denmark Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Sweden Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Sweden Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Norway Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Norway Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Japan Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 China Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 China Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 57 China Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 India Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 India Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 India Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Australia Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Australia Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 66 South Korea Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Thailand Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 Thailand Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Latin America Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Latin America Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 Brazil Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 Brazil Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Argentina Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 79 Argentina Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 South Africa Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 86 South Africa Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 UAE Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 UAE Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Fondaparinux Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Type and Product Outlook (USD Million)
  • Fig. 10 Distribution Channel Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Fondaparinux Market Dynamics
  • Fig. 13 Fondaparinux Market: Porter's Five Forces Analysis
  • Fig. 14 Fondaparinux Market: PESTLE Analysis
  • Fig. 15 Fondaparinux Market: Type Segment Dashboard
  • Fig. 16 Fondaparinux Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 17 Deep Vein Thrombosis Market, 2018 - 2030 (USD Million)
  • Fig. 18 Pulmonary Embolism Market, 2018 - 2030 (USD Million)
  • Fig. 19 Fondaparinux Market: Product Segment Dashboard
  • Fig. 20 Fondaparinux Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 21 Branded Market, 2018 - 2030 (USD Million)
  • Fig. 22 Generic Market, 2018 - 2030 (USD Million)
  • Fig. 23 Fondaparinux Market: Distribution Channel Segment Dashboard
  • Fig. 24 Fondaparinux Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 25 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 26 Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 27 Online Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 28 Fondaparinux Market Revenue, By Region
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 North America Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Country Dynamics
  • Fig. 33 U.S. Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Country Dynamics
  • Fig. 35 Canada Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico Country Dynamics
  • Fig. 37 Mexico Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Country Dynamics
  • Fig. 40 UK Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Country Dynamics
  • Fig. 42 Germany Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Country Dynamics
  • Fig. 44 France Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy Country Dynamics
  • Fig. 46 Italy Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Country Dynamics
  • Fig. 48 Spain Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Country Dynamics
  • Fig. 50 Norway Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden Country Dynamics
  • Fig. 52 Sweden Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark Country Dynamics
  • Fig. 54 Denmark Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Country Dynamics
  • Fig. 57 Japan Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 58 China Country Dynamics
  • Fig. 59 China Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 60 India Country Dynamics
  • Fig. 61 India Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Country Dynamics
  • Fig. 63 Australia Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Country Dynamics
  • Fig. 65 South Korea Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand Country Dynamics
  • Fig. 67 Thailand Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil Country Dynamics
  • Fig. 70 Brazil Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina Country Dynamics
  • Fig. 72 Argentina Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa Country Dynamics
  • Fig. 75 South Africa Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia Country Dynamics
  • Fig. 77 Saudi Arabia Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 78 UAE Country Dynamics
  • Fig. 79 UAE Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait Country Dynamics
  • Fig. 81 Kuwait Fondaparinux Market, 2018 - 2030 (USD Million)
  • Fig. 82 Company Categorization
  • Fig. 83 Company Market Position Analysis
  • Fig. 84 Strategic Framework